Madrigal Pharmaceuticals, Inc. (MDGL) Insider Trading
Over the last 3 months, MDGL insiders made 0 open-market buys and 13 sales, a net sale of -$3.9M (SEC Form 4). Over the last 6 months, 274 institutions increased and 254 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
13
Net (3m)
-$3.9M
Insider trades by month Buys Sells
Nov
Dec
Jan
Mar
May
Jun
Context3-month price +2.6%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 18, 2026 | Daly James Mdirector | Grant | 454 | — |
| Jun 18, 2026 | BAKER BROS. ADVISORS LPdirector | Grant | 908 | — |
| Jun 18, 2026 | Levy Richard Sdirector | Grant | 766 | $499.86 |
| Jun 18, 2026 | Brennan Daniel J.director | Grant | 404 | — |
| Jun 18, 2026 | BAKER BROS. ADVISORS LPdirector | Grant | 1,532 | $499.86 |
| Jun 18, 2026 | FOUSE JACQUALYN Adirector | Grant | 766 | $499.86 |
| Jun 18, 2026 | Levy Richard Sdirector | Grant | 454 | — |
| Jun 18, 2026 | Daly James Mdirector | Grant | 766 | $499.86 |
| Jun 18, 2026 | FOUSE JACQUALYN Adirector | Grant | 454 | — |
| Jun 18, 2026 | Taub Rebeccadirector | Grant | 766 | $499.86 |
| Jun 18, 2026 | Taub Rebeccadirector | Grant | 454 | — |
| Jun 18, 2026 | Brennan Daniel J.director | Grant | 681 | $499.86 |
| Jun 1, 2026 | Soergel Davidofficer: Chief Medical Officer | Sell | 1,042 | $495.74 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 1,497 | $517.59 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 343 | $514.67 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 610 | $511.40 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 723 | $516.87 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 657 | $515.92 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 151 | $510.36 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 80 | $519.98 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 439 | $512.50 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 320 | $508.24 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 40 | $506.68 |
| May 22, 2026 | Levy Richard Sdirector | Sell | 782 | $518.76 |
| May 18, 2026 | Soergel Davidofficer: Chief Medical Officer | Sell | 844 | $515.90 |
| Mar 6, 2026 | Dier Mardiofficer: EVP and CFO | Grant | 5,215 | — |
| Mar 6, 2026 | Dier Mardiofficer: EVP and CFO | Sell | 40 | $425.08 |
| Mar 6, 2026 | Dier Mardiofficer: EVP and CFO | Grant | 6,519 | $434.80 |
| Mar 6, 2026 | Dier Mardiofficer: EVP and CFO | Sell | 120 | $430.90 |
| Mar 6, 2026 | Sibold William Johndirector, officer: President and CEO | Grant | 18,743 | $434.80 |
Source: MDGL SEC Form 4 filings, latest Jun 18, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their MDGL positions over the last 6 months (SEC Form 13F).
Increased
274
New positions
144
Reduced
254
Sold out
108
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | 4.0M | May 18, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 2.1M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 2.1M | Feb 17, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 2.0M | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 2.0M | Feb 17, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 1.8M | May 15, 2026 |
| VANGUARD GROUP INC | Reduced | 1.8M | Jan 29, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 1.8M | Mar 16, 2026 |
| PAULSON & CO. INC. | Reduced | 1.7M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.7M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 1.6M | Feb 12, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 1.6M | Feb 17, 2026 |
| BLACKROCK, INC. | Reduced | 1.6M | May 13, 2026 |
| PAULSON & CO. INC. | Reduced | 1.4M | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 841K | May 8, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.